[HTML][HTML] Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression

K Shiizaki, A Tsubouchi, Y Miura, K Seo… - The Journal of …, 2021 - Am Soc Clin Investig
… of phosphate binders have been applied for patients with … progression of early-stage CKD
to end-stage renal disease (… a net effect of bicarbonate on renal therapy outcomes in patients

Systemic vasculature in chronic kidney disease. third part

F Inserra, G Lavenia, P Forcada… - Revista de Nefrología …, 2024 - medigraphic.com
… various therapeutic alternatives for vascular stiffness in patients with chronic kidney disease.
… aGLP-1 in particular, and their effect on blood pressure and vascular stiffness, particularly in …

[HTML][HTML] FGF23 and phosphatecardiovascular toxins in CKD

I Vogt, D Haffner, M Leifheit-Nestler - Toxins, 2019 - mdpi.com
… However, clinical trials proving the effects on the cardiovascular … in chronic kidney disease
(CKD) patients is cardiovascular … a phosphate binder therapy in CKD patients are still lacking. …

[HTML][HTML] Magnesium and Vascular Calcification in Chronic Kidney Disease: Current Insights

SJ Zaslow, GH Oliveira-Paula, W Chen - International Journal of …, 2024 - mdpi.com
phosphate binder. Consistent with these results, other studies also observed protective
effects of Mg against vascular … with early-stage CKD, who have not yet developed vascular

[HTML][HTML] Oxidative stress contributes to vascular calcification in patients with chronic kidney disease

M Huang, L Zheng, H Xu, D Tang, L Lin, J Zhang… - Journal of Molecular and …, 2020 - Elsevier
… to cardiovascular mortality in patients with CKD. Associations with the pathological impact of
CKD… We observed a significant upregulation of NOX1 in arteries of rats with early stage CKD …

The effect of magnesium supplementation on vascular calcification in chronic kidney disease—A randomised clinical trial (MAGiCAL-CKD): Essential study design and …

I Bressendorff, D Hansen, M Schou, C Kragelund… - BMJ open, 2017 - bmjopen.bmj.com
… has been shown in a previous trial of phosphate binder treatment in CKD stage 3–5.34 …
Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease

Calcium-Phosphate Metabolism Disorders in Patients with Renal Failure Clinical Significance, Diagnosis and Treatment

V Grozeva, A Kundurzhiev - Acta Medica Bulgarica, 2019 - sciendo.com
Chronic kidney diseases (CKD) are commonly associated … early-stage CKD patients may
delay the progression of bone … phosphate levels can be controlled with phosphate binders such …

Magnesium to prevent kidney disease–associated vascular calcification: crystal clear?

AD Ter Braake, MG Vervloet… - Nephrology Dialysis …, 2022 - academic.oup.com
… for cardiovascular mortality in chronic kidney disease (CKD) … reported promising effects of
low-dose vitamin D 3 treatment in … However, patients with early-stage CKD have normal blood …

[PDF][PDF] Complications of Chronic Kidney Disease

K Blair - CE for Arizona Pharmacy Professionals, 2018 - s3.amazonaws.com
… and prevention of adverse effects of chronic kidney disease … be used safely in early-stage
CKD patients. References should … more than calcium containing phosphate binders, and may …

Finerenone reduces intrinsic arterial stiffness in Munich Wistar Frömter rats, a genetic model of chronic kidney disease

M Gil-Ortega, E Vega-Martín, M Martín-Ramos… - American Journal of …, 2020 - karger.com
… We hypothesize that FIN reduces arterial stiffness in this model associated to … Effect of
spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease